Intl. Biotechnology Trust PLC Portfolio Update (2653U)
16 January 2017 - 10:40PM
UK Regulatory
TIDMIBT
RNS Number : 2653U
Intl. Biotechnology Trust PLC
16 January 2017
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)
Portfolio Update as at 31 December 2016
Net Assets GBP225m
Net Assets per share 599p
Share price 550p
Total value of unquoted GBP26m
investments
Total number of portfolio
companies 77
Top Ten Holdings
Company Name % NAV
Celgene 7.6
Biogen 6.7
Genmab 6.3
Alexion 5.9
Shire 5.8
Tesaro 4.6
Gilead 4.5
Regeneron 4.3
Amgen 4.2
Novo 3.4
-----------
Total 53.3
Geographical Allocation % NAV
US & Canada 78
Europe & UK 22
-----------
Total 100
Quoted/Unquoted Allocation % NAV
Quoted 89
Unquoted 11
-----------
Total 100
NAV % Market Cap % NAV
Large Cap >USD10BN 58
Mid Cap =USD1-10BN 21
Small Cap <USD1BN 21
-----------
Total 100
NAV % by Therapeutic Areas % NAV
Oncology 38
Orphan 12
CNS 11
Inflammation 8
Ophthalmology 5
Medtech 3
Other 23
-----------
Total 100
BNP Paribas Secretarial Services Limited
Company Secretary
16 JANUARY 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
PFUBBGDBCXBBGRL
(END) Dow Jones Newswires
January 16, 2017 06:40 ET (11:40 GMT)
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From Apr 2024 to May 2024
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From May 2023 to May 2024